Atrás

3SBio Inc.

Calidad de datos: 100%

TRSBF

OTC Healthcare Biotechnology

$2.58

$0.00 (0.00%)

Cap. Mercado: 6.09B

Rango del Día

$2.58 $3.56

Rango de 52 Semanas

$0.83 $4.74

Volumen

1,000

Promedio 50D / 200D

$2.91 / $3.49

Cierre Anterior

$2.58

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica	Acción	Mediana del Sector
P/E	2.9	0.3
P/B	0.4	3.0
ROE %	14.2	3.7
Net Margin %	23.0	3.8
Rev Growth 5Y %	13.0	10.0
D/E	0.2	0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período	EPS Est.	Ingresos Est.	Analistas
FY2027	$1.39 $1.09 – $1.86	11.75B	1
FY2026	$1.30 $1.02 – $1.73	11.24B	1

Earnings Surprises

Last 8 quarters

Quarter	Est. EPS	Actual EPS	Surprise
2025-08-29	$0.08	$0.08	-0.9%
2025-03-25	$0.06	$0.06	-5.7%
2024-08-22	$0.06	$0.06	+1.9%
2024-06-25	$0.06	$0.03	-41.6%
2023-06-30	$0.05	$0.06	+14.8%
2023-03-21	$0.05	$0.05	+1.3%
2022-08-24	$0.04	$0.05	+20.5%
2022-03-28	$0.04	$0.04	+8.2%

Dividend History

Yield

0.04%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 12.99% annually over 5 years — strong growth

Earnings grew 34.93% over the past year

ROE of 14.19% — decent returns on equity

Net margin of 22.95% shows strong profitability

Debt/Equity of 0.23 — conservative balance sheet

Generating 2.24B in free cash flow

Crecimiento

Revenue Growth (5Y)

12.99%

Revenue (1Y)16.53%

Earnings (1Y)34.93%

FCF Growth (3Y)36.19%

Calidad

Return on Equity

14.19%

ROIC10.79%

Net Margin22.95%

Op. Margin29.99%

Seguridad

Debt / Equity

0.23

Current Ratio1.71

Interest Coverage14.31

Valoración

P/E Ratio

2.91

Forward P/EN/A

P/B Ratio0.39

EV/EBITDA2.79

Dividend Yield0.04%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	16.53%	Revenue Growth (3Y)	15.23%
Earnings Growth (1Y)	34.93%	Earnings Growth (3Y)	4.46%
Revenue Growth (5Y)	12.99%	Earnings Growth (5Y)	25.76%
Profitability
Revenue (TTM)	9.11B	Net Income (TTM)	2.09B
ROE	14.19%	ROA	8.63%
Gross Margin	85.95%	Operating Margin	29.99%
Net Margin	22.95%	Free Cash Flow (TTM)	2.24B
ROIC	10.79%	FCF Growth (3Y)	36.19%
Safety
Debt / Equity	0.23	Current Ratio	1.71
Interest Coverage	14.31
Dividends
Dividend Yield	0.04%	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	2.91	Forward P/E	N/A
P/B Ratio	0.39	P/S Ratio	0.67
PEG Ratio	0.19	Forward PEG	N/A
EV/EBITDA	2.79	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	36.77%
Market Cap	6.09B	Enterprise Value	7.62B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	9.11B	7.82B	6.86B	6.38B	5.59B
Net Income	2.09B	1.55B	1.92B	1.65B	835.79M
EPS (Diluted)	0.85	0.62	0.74	0.62	0.33
Gross Profit	7.83B	6.64B	5.67B	5.28B	4.52B
Operating Income	2.73B	2.46B	2.07B	1.83B	1.46B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Total Assets	24.21B	23.63B	21.99B	19.21B	17.68B
Total Liabilities	6.18B	7.11B	6.59B	4.55B	4.58B
Shareholders' Equity	15.44B	14.03B	12.96B	12.23B	10.69B
Total Debt	3.55B	4.84B	4.52B	2.63B	2.91B
Cash & Equivalents	2.02B	2.69B	2.15B	2.80B	3.09B
Current Assets	9.35B	9.19B	9.76B	7.79B	6.68B
Current Liabilities	5.46B	3.73B	1.79B	1.42B	1.45B

Puntuaciones de Estrategias

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)

Rank = position among all matches

Custom Cash Flow Compounder

#523 of 1052

Custom Deep Value Investing (Seth Klarman)

#39 of 827

Growth Price/Sales Ratio Focus (Ken Fisher)

#250 of 618

Value Defensive Investing (Benjamin Graham)

#11 of 709

Actividad Reciente

Entró Cash Flow Compounder

Mar 24, 2026

Entró Deep Value Investing (Seth Klarman)

Mar 24, 2026

Entró Price/Sales Ratio Focus (Ken Fisher)

Mar 24, 2026

Entró Defensive Investing (Benjamin Graham)

Mar 24, 2026